Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer.

Anticancer research - 1 Feb 2023

Oh Chung Ryul, Kim Hyung-Don, Ryu Yeon-Mi, Lee Seonmin, Kim Danbee, Lee DA Sol, Jeong Jae Ho, Chang Heung-Moon, Ryoo Baek-Yeol, Kim Kyu-Pyo, Kim Miyeon, Kim Sang-Yeob, Yoo Changhoon

Abstract excerpt

BACKGROUND/AIM: This study evaluated the clinical implications of epithelial-mesenchymal transition (EMT) markers and peritumoral immune cell infiltration in patients with biliary tract cancer (BTC) treated with gemcitabine plus cisplatin (GemCis). MATERIALS AND METHODS: Forty-five patients with advanced BTC who received GemCis were included as the study population. We conducted multiplex immunohistochemistry and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bile Duct Neoplasms
Share to Biliary Tract Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Cadherins

Share to Deoxycytidine

Share to Epithelial-Mesenchymal Transition

Share to Phenotype

Share to Vimentin

Source

Identifiers

PMID: 36697100
DOI: 10.21873/anticanres.16201

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer.PMID 36697100Read ↗

Epithelial–Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract CancerSemantic proximity Read ↗

KRAS mutations disrupt interactions between CD8+ T cells and antigen-presenting cells in the tumor microenvironment of biliary tract cancer.Semantic proximity Read ↗

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?Semantic proximity Read ↗

Characterisation of the immune-related transcriptome in resected biliary tract cancersSemantic proximity Read ↗

Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

SPARC Accelerates Biliary Tract Cancer Progression through CTGF-mediated Tumor-Stroma interactions: SPARC as a Prognostic Marker of Survival after Neoadjuvant TherapySemantic proximity Read ↗

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.Semantic proximity Read ↗

Gemcitabine plus Oxaliplatin (GEMOX) combined with Atezolizumab and Bevacizumab for Advanced Biliary Tract Cancer: A Preliminary Observational StudySemantic proximity Read ↗

Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland TumorsSemantic proximity Read ↗

Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.